Candriam SCA’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-992,510
| Closed | -$45.8M | – | 847 |
|
|
2019
Q2 | $45.8M | Sell |
992,510
-612,970
| -38% | -$28.3M | 0.57% | 28 |
|
|
2019
Q1 | $39.1M | Sell |
1,605,480
-73,230
| -4% | -$1.79M | 0.5% | 42 |
|
|
2018
Q4 | $23.9M | Buy |
1,678,710
+327,522
| +24% | +$4.67M | 0.37% | 52 |
|
|
2018
Q3 | $20.5M | Buy |
1,351,188
+601,300
| +80% | +$9.14M | 0.27% | 79 |
|
|
2018
Q2 | $12.6M | Buy |
749,888
+174,888
| +30% | +$2.93M | 0.2% | 131 |
|
|
2018
Q1 | $9.38M | Buy |
575,000
+35,000
| +6% | +$571K | 0.16% | 169 |
|
|
2017
Q4 | $6.91M | Sell |
540,000
-204,000
| -27% | -$2.61M | 0.12% | 211 |
|
|
2017
Q3 | $9.15M | Buy |
744,000
+279,000
| +60% | +$3.43M | 0.16% | 167 |
|
|
2017
Q2 | $3.89M | Buy |
465,000
+10,000
| +2% | +$83.7K | 0.07% | 321 |
|
|
2017
Q1 | $4.07M | Sell |
455,000
-300,000
| -40% | -$2.68M | 0.08% | 292 |
|
|
2016
Q4 | $6.64M | Sell |
755,000
-55,000
| -7% | -$483K | 0.15% | 167 |
|
|
2016
Q3 | $5.47M | Sell |
810,000
-39,000
| -5% | -$263K | 0.13% | 179 |
|
|
2016
Q2 | $3.02M | Buy |
849,000
+190,000
| +29% | +$677K | 0.08% | 249 |
|
|
2016
Q1 | $1.93M | Buy |
+659,000
| New | +$1.93M | 0.05% | 327 |
|